Atrial fibrillation (AF) and cognitive impairment in the elderly: a case-control study

A Bellomo1, G De Benedetto, C Fossati

  • 1Department of Cardiovascular, Respiratory, Nephrological and Geriatric Sciences, Sapienza University of Rome, Umberto I, Policlinico di Roma, Viale del Policlinico 155, I-00161 Roma, Italy.

Insights

Atrial fibrillation (AF) is linked to cognitive decline and depression, even without a history of stroke. This study found early-stage cognitive impairment and higher depression risks in AF patients.

Area of Science:

  • Cardiology
  • Neurology
  • Geriatrics

Background:

  • Atrial fibrillation (AF) can impair cerebral perfusion, increasing cognitive decline risk.
  • The impact of AF on dementia and depression, especially in patients without prior strokes, requires further investigation.

Purpose of the Study:

  • To evaluate the association between atrial fibrillation (AF), dementia, and depression.
  • To assess cognitive and behavioral functions in patients with and without AF, excluding those with a history of stroke.

Main Methods:

  • A Multidimensional Geriatric Assessment was performed on 26 AF patients and 31 controls (sinus rhythm).
  • Cognitive function was assessed using the Mini Mental State Examination (MMSE).
  • Depression risk was evaluated using the Geriatric Depression Scale (GDS).

Main Results:

  • AF patients exhibited significantly lower MMSE scores compared to controls (p<0.05).
  • AF patients showed higher GDS scores, indicating an increased risk of depression (p<0.02).
  • A statistically significant association was found between AF, depression, and early-stage cognitive impairment.

Conclusions:

  • Atrial fibrillation is associated with an increased risk of cognitive impairment and depression.
  • AF may be considered a risk factor for dementia and depression, independent of stroke history.
  • Early detection and management of AF may be crucial for preventing cognitive decline and depression.

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...